Literature DB >> 15478025

MR imaging of spinal infection.

Bernhard J Tins1, Victor N Cassar-Pullicino.   

Abstract

Magnetic resonance (MR) imaging plays a pivotal role in the diagnosis and management of spinal infection, enjoying a high sensitivity and specificity. A thorough understanding of spinal anatomy and the physicochemical pathological processes associated with infection is a desirable prerequisite allowing accurate interpretation of the disease process. Apart from confirmation of the disease, MR imaging is also best suited to excluding multifocal spinal involvement and the detection/exclusion of complications. It plays an essential role in the decision-making process concerning conservative versus surgical treatment and is also the best imaging method to monitor the effect of treatment. The MR features of infection confidently exclude tumor, degeneration, and so forth as the underlying process; differentiate pyogenic from granulomatous infections in most cases; and can suggest the rarer specific infective organisms. Copyright 2004 Thieme Medical Publishers, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15478025     DOI: 10.1055/s-2004-835362

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  17 in total

Review 1.  Imaging findings of Pott's disease.

Authors:  Antonio Rivas-Garcia; Silvana Sarria-Estrada; Carme Torrents-Odin; Lourdes Casas-Gomila; Elisa Franquet
Journal:  Eur Spine J       Date:  2012-06-09       Impact factor: 3.134

2.  [Radiological diagnostics of inflammatory spinal diseases: what is the state of the art?].

Authors:  M Eichler; M-A Weber; S Hähnel; C H Rehnitz
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

3.  Joint EANM/ESNR and ESCMID-endorsed consensus document for the diagnosis of spine infection (spondylodiscitis) in adults.

Authors:  Elena Lazzeri; Alessandro Bozzao; Maria Adriana Cataldo; Nicola Petrosillo; Luigi Manfrè; Andrej Trampuz; Alberto Signore; Mario Muto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-09       Impact factor: 9.236

4.  Categorization of Pathology Causing Low Back Pain using Magnetic Resonance Imaging (MRI).

Authors:  Nirmalkumar Gopalakrishnan; Kulasekaran Nadhamuni; T Karthikeyan
Journal:  J Clin Diagn Res       Date:  2015-01-01

5.  New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years.

Authors:  Enrico Pola; G Autore; V M Formica; V Pambianco; D Colangelo; R Cauda; M Fantoni
Journal:  Eur Spine J       Date:  2017-03-21       Impact factor: 3.134

6.  Pyogenic and non-pyogenic spinal infections: emphasis on diffusion-weighted imaging for the detection of abscesses and pus collections.

Authors:  T Moritani; J Kim; A A Capizzano; P Kirby; J Kademian; Y Sato
Journal:  Br J Radiol       Date:  2014-07-07       Impact factor: 3.039

7.  Utility of MRI in the follow-up of pyogenic spinal infection in children.

Authors:  Qiuyan Wang; Paul Babyn; Helen Branson; Dat Tran; Jorge Davila; Edrise L Mueller
Journal:  Pediatr Radiol       Date:  2009-09-10

8.  Clinical Utility of Diffusion-Weighted Imaging in Spinal Infections.

Authors:  Rebecca A Dumont; Nayela N Keen; Courtnay W Bloomer; Brian S Schwartz; Jason Talbott; Aaron J Clark; David M Wilson; Cynthia T Chin
Journal:  Clin Neuroradiol       Date:  2018-03-26       Impact factor: 3.649

9.  Follow-up MR imaging in patients with pyogenic spine infections: lack of correlation with clinical features.

Authors:  T J Kowalski; K F Layton; E F Berbari; J M Steckelberg; P M Huddleston; J T Wald; D R Osmon
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

10.  Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis.

Authors:  Elda Righi; Alessia Carnelutti; Daniele Muser; Fernando Di Gregorio; Barbara Cadeo; Giulia Melchioretto; Maria Merelli; Abass Alavi; Matteo Bassetti
Journal:  Skeletal Radiol       Date:  2020-01-04       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.